Literature DB >> 14998482

PP2A fulfills its promises as tumor suppressor: which subunits are important?

Christine Van Hoof1, Jozef Goris.   

Abstract

Reversible phosphorylation of proteins, catalyzed by kinases and phosphatases, is a key regulatory mechanism in the control of multiple cellular signal transduction pathways. Uncontrolled regulation by the altered phosphorylation state of the components of these pathways often leads to increased cell proliferation and cell transformation. Many viruses encode oncogenic proteins, required for their efficient viral replication, which deregulate the activity of host cell proteins. This might program cells to a malignant state, underlying the molecular mechanism of tumor formation and cancer development. Recent studies reveal a role for a specific form of protein phosphatase 2A (PP2A) in viral-induced cell transformation by interaction with the small t antigen (ST) of the DNA tumor simian virus 40 (SV40).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998482     DOI: 10.1016/s1535-6108(04)00027-3

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  19 in total

1.  Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.

Authors:  Yikun Li; Ping Yue; Xingming Deng; Takeshi Ueda; Rikiro Fukunaga; Fadlo R Khuri; Shi-Yong Sun
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55.

Authors:  Heng-Hong Li; Xin Cai; Geoffrey P Shouse; Landon G Piluso; Xuan Liu
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

3.  Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation.

Authors:  Alessandra Magenta; Pasquale Fasanaro; Sveva Romani; Valeria Di Stefano; Maurizio C Capogrossi; Fabio Martelli
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

4.  Acute regulation of renal Na+/H+ exchanger NHE3 by dopamine: role of protein phosphatase 2A.

Authors:  I Alexandru Bobulescu; Henry Quiñones; Serge M Gisler; Francesca Di Sole; Ming-Chang Hu; Mingjun Shi; Jianning Zhang; Daniel G Fuster; Nancy Wright; Marc Mumby; Orson W Moe
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-24

5.  InAKTivation of insulin/IGF-1 signaling by dephosphorylation.

Authors:  Sri Devi Narasimhan; Arnab Mukhopadhyay; Heidi A Tissenbaum
Journal:  Cell Cycle       Date:  2009-12       Impact factor: 4.534

6.  Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.

Authors:  Hugh K Arnold; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.

Authors:  Marilyn Goudreault; Lisa M D'Ambrosio; Michelle J Kean; Michael J Mullin; Brett G Larsen; Amy Sanchez; Sidharth Chaudhry; Ginny I Chen; Frank Sicheri; Alexey I Nesvizhskii; Ruedi Aebersold; Brian Raught; Anne-Claude Gingras
Journal:  Mol Cell Proteomics       Date:  2008-09-08       Impact factor: 5.911

Review 8.  Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation.

Authors:  Kamel Khalili; Ilker Kudret Sariyer; Mahmut Safak
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

9.  The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters.

Authors:  Joo Ae Kim; Youngmi Kim; Byoung-Mog Kwon; Dong Cho Han
Journal:  J Biol Chem       Date:  2013-08-27       Impact factor: 5.157

Review 10.  Role of "oncogenic nexus" of CIP2A in breast oncogenesis: how does it work?

Authors:  Pradip De; Jennifer H Carlson; Brian Leyland-Jones; Nandini Dey
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.